The number of COX-2+ TAMs was associated with increased clinical staging (p = 0.024) and aggressive tumor biology by advanced histopathological grading (p < 0.001) and lymph node metastasis (p = 0.021) (Table 1). This evidence concerns the gene PTGS2 and metastatic malignant neoplasm in the lymph nodes.